SPOTLIGHT -
EP. 1: Pancreatic Neuroendocrine Tumor Diagnosis Challenges
EP. 2: Pathologic Classification of Neuroendocrine Tumors
EP. 3: Treatment of Neuroendocrine Tumor Liver Metastases
EP. 4: Alkylating Agents in Pancreatic Neuroendocrine Tumors
EP. 5: Role of Somatostatin Analogs for Patients With pNETs
EP. 6: Everolimus in Pancreatic Neuroendocrine Tumors
EP. 7: RADIANT-3 Trial: Everolimus for Patients With pNETs
EP. 8: Utilizing Everolimus and Sunitinib in pNETs
EP. 9: Case Study: Treating Metastatic Pancreatic NETs
EP. 10: Treatment Sequencing and Combinations in pNETs
EP. 11: Conclusion: Effective Sequencing of Treatments for pNETs
Further Understanding of Immune Mechanisms in Tumor Microenvironment Is Key to Advancing Immunotherapy in Solid Tumors
Navigating Systemic Therapy for RCC: Balancing Risk Status and Response
ADCs, Novel Targets Represent Next Wave of Treatment Advances in mCRPC
Precision Medicine in Prostate Cancer Care: Keeping Up With Evolving Guidance for Testing and Decision Making
